IL-23 production by cDCs may be protective in acute colitis models such as DSS-induced colitis, whereas IL-23 upregulation by CX3CR1+ macrophages exacerbates chronic colitis models, including those induced by IL-10 deficiency or anti-CD40 agonistic antibody injection. Here, CD40 is linked to colitis.